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Abstract
Medulloblastoma is a cerebellar tumor that can arise through aberrant activation of Sonic hedgehog (Shh) signaling, which normally
regulates cerebellar granule cell proliferation. Mutations of the Shh receptor PATCHED (PTCH) are associated with medulloblastomas,
which have not been found to have loss of PTCH heterozygosity. We address whether patched (Ptc) heterozygosity fundamentally alters
granule cell differentiation and contributes to tumorigenesis by increasing proliferation and/or decreasing apoptosis in Ptc/ mice. Our
data show that postnatal Ptc/ mouse granule cell precursor growth is not globally altered. However, many older Ptc/ mice display
abnormal cerebellar regions containing persistently proliferating granule cell precursors. Since fewer Ptc/ mice form medulloblastomas,
these granule cell rests represent a developmentally disrupted, but uncommitted stage of tumorigenesis. Although Ptc/ mouse
medulloblastomas express neurodevelopmental genes, they diverge from granule cell differentiation in their discordant coexpression of
postmitotic markers despite their ongoing growth. Like human medulloblastomas, mouse tumors with reduced levels of the neurotrophin-3
receptor, trkC/Ntrk3, display decreased apoptosis in vivo, illustrating the role of TrkC in regulating tumor cell survival. These results
indicate that Ptc heterozygosity contributes to tumorigenesis by predisposing a subset of granule cell precursors to the formation of
proliferative rests and subsequent dysregulation of developmental gene expression.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Recent evidence links brain tumor oncogenesis to mech-
anisms of normal brain development. Medulloblastoma is
the most common malignant brain tumor of childhood
(Chintagumpala et al., 2001). The histogenesis of human
medulloblastoma in the cerebellar granule cell lineage is
supported by their expression of developmentally regulated
granule cell-specific markers (Giangaspero, et al., 2000;
Kadin, et al., 1970; Kozmik et al., 1995; Pomeroy et al.,
2002; Yokota et al., 1996). Unlike most neuronal popula-
tions, granule cell precursors remain mitotically active even
after birth and constitute potential targets of transforming
insults (Wang and Zoghbi, 2001).
Activation of Sonic hedgehog (Shh) signaling normally
regulates granule cell proliferation and differentiation but
can also contribute to medulloblastoma formation (Dah-
mane et al., 2001; Wechsler-Reya and Scott, 1999). Humans
with Gorlin’s or nevoid basal cell carcinoma syndrome
(NBCCS) and germline mutations of the Shh receptor gene,
PATCHED (PTCH), are predisposed to medulloblastoma
tumorigenesis (Gorlin, 1995; Hahn et al., 1996; Johnson et
al., 1996). Mice with heterozygous patched (Ptc/Ptc1) mu-
tation are also susceptible to medulloblastoma formation
(Goodrich et al., 1997; Hahn et al., 2000). However, only a
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minority of either NBCCS patients or Ptc/mice go on to
develop medulloblastomas, which do not feature loss of
heterozygosity of the remaining wild-type PTCH or Ptc
allele, respectively (Dong et al., 2000; Wetmore et al.,
2000). Since Ptc does not appear to act as a classical tumor
suppressor, we investigated whether Ptc heterozygosity it-
self contributes to medulloblastoma tumorigenesis by dis-
rupting granule cell development.
Normally, granule cells arise from committed precursors
that migrate during late embryonic development over the
surface of the cerebellar anlage to form a superficial germi-
nal layer known as the external granule cell or external
granular layer (EGL) (Altman and Bayer, 1997; Rakic,
1973; Wang and Zoghbi, 2001). Perinatally, the EGL ex-
pands dramatically as immature granule cell precursors in
the outermost regions proliferate under the mitogenic influ-
ence of Shh (Wechsler-Reya and Scott 1999). In the deeper
region EGL, granule cells withdraw from the cell cycle and
migrate inward, terminally differentiating in the internal
granule cell layer (IGL).
Our data indicate that, rather than globally increasing
proliferation or constitutively decreasing apoptosis in gran-
ule cell precursors of the EGL, Ptc heterozygosity instead
perturbs differentiation in only a subset of EGL cells by
promoting the abnormal proliferation in a significant frac-
tion of Ptc/ mice. Since only a smaller minority of
Ptc/ mice eventually form medulloblastomas, the
greater incidence of these EGL rests indicates that they
represent potential but not committed premalignant lesions.
We also find that Ptc/ mouse medulloblastomas para-
doxically express markers of postmitotic granule cells that
belie their ongoing cell division. Murine medulloblastomas
express a wide range of neuronal and granule cell-specific
markers previously described in primary human tumors and
appear similar to the desmoplastic subtype of human me-
dulloblastoma.
We addressed whether other signaling molecules critical
for granule cell differentiation regulate tumor progression
by testing the role of the neurotrophin-3 receptor, TrkC, a
clinically significant prognostic indicator associated with
apoptosis in human medulloblastoma (Segal et al., 1994;
Kim et al., 1999; Grotzer et al., 2000). We crossbred the
Ptc/ mouse with the heterozygous trkC/ strain con-
taining a mutant trkC (Ntrk3) allele that lacks the tyrosine
kinase-signaling domain to generate double heterozygous
trkC/Ptc/ mice (Klein et al., 1994). Medulloblasto-
mas from trkC/Ptc/ mice express lower levels of
trkC and display decreased apoptosis compared with tumors
from parental Ptc/ mice, supporting the in vivo role of
TrkC in modulating tumor cell survival.
We conclude that germline Ptc heterozygosity does not
globally alter growth, but instead predisposes a subpopula-
tion of granule cell precursors to form proliferative rests that
represent potential targets of additional mutations and sub-
sequent dysregulation of developmental gene expression
that contribute to medulloblastoma tumorigenesis.
Materials and methods
Animals
Heterozygous patched (Ptc/) mice (kindly provided
by Matthew P. Scott (Stanford University, Stanford, CA)
and heterozygous trkC (trkC/) mice [B6, 129-Ntrk3tm1
kindly provided by Immaculada Silos-Santiago (Millen-
nium Pharmaceuticals, Cambridge, MA)] were maintained
on a mixed C57B1/6  129Sv background, including 573
Ptc/ and 163 trkC/ animals (Goodrich et al., 1997;
Klein et al., 1994). Both heterozygous parental strains were
crossed to generate compound heterozygous trkC/
Ptc/ offspring (n  82). All mice were housed in a
barrier facility according to N.I.H., U.S.D.A., and institu-
tional (Children’s Hospital, Boston, MA) guidelines and
regulations. Animals were monitored daily until at least 100
weeks old for signs of illness and behavioral evidence of
tumor, such as lethargy, decreased grooming, weight loss,
or ataxia. Symptomatic mice were euthanized and their
brain tissue processed as described below. All animals with
confirmed genotypes were included in statistical analyses
regardless of cause of death.
Polymerase chain reaction
Genotyping was performed on genomic DNA from tail
biopsies obtained at weaning, based on previously described
methods (Goodrich et al., 1997; Schimmang et al., 1995).
For Ptc genotyping, the primer pair WT3 (5-CTGCG-
GCAAGTTTTTGGTTG-3) and WT4 (5-AGGGCT-
TCTCGTTGGCTACAAG-3) yield target sequences from
the wild-type (wt) Ptc allele, and the primer pair NeoF2
(5-GGATGATCTGGACGAAGAGC-3) and NeoB2 (5-
AGAAGGCGATAGAAGGCGAT-3) yield target se-
quences from the neoR transgene. For trkC genotyping, the
common 5 primer, P093-1 (5-CTGAAGTCACTGGCTA-
GAG-TCTGGG-3), with the 3 wt primer, P092-1 (5-
GTCCCATCTTGCTTA-CCCTGAGG-3), yields a 380-bp
target from the wt trkC allele, or with the 3 mutant primer
P098-0 (5-CCAGCCTCTGAGCCCAGAAAGC-3) yields
a 500-bp target from the pgk-1 promoter of the neoR cas-
sette.
Tissue processing and RNA preparation
Brain and tumor tissue was obtained from euthanized
mice for either RNA isolation or postfixation and subse-
quent sectioning, as previously described (Kim et al., 1999).
For brain and tissue sections, mice were euthanized by
intraperitoneal Avertin overdose before intracardiac perfu-
sion with ice-cold paraformaldehyde [PFA, 4% (w/v) in
PBS; Sigma, St. Louis, MO]. Tumor tissue was dissected
from surrounding normal brain tissue, postfixed overnight
for 12–18 h in 4% PFA/PBS at 4°C. For frozen sections,
postfixed tissue was cryoprotected in 20% sucrose/PBS
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(w/v) before flash freezing in liquid nitrogen, embedding in
Tissue-Tek O.C.T. compound (Sakura Finetek, Torrance,
CA), and storage at 80°C. Glass slides were used for all
tissue sections (Superfrost, Fisher Scientific, Pittsburgh,
PA). Frozen 7.5-and 10-m cryostat sections (Leica Jung
Frigicut 2800E) were prepared and stored at 80°C for in
situ hybridization, immunofluorescent staining, prolifera-
tion, and apoptosis assays. To confirm the presence of
neoplastic cells, paraffinized 5-m sections were prepared
from postfixed tissue by using a rotary microtome
(Reichert-Jung 2050) and rehydrated through xylene/etha-
nol series for staining with cresyl violet or hematoxylin and
eosin according to standard methods or for reticulin using
Gomori’s method employed for human desmoplastic me-
dulloblastoma (Luna, 1968).
Immunophenotyping
Antibodies used to characterize tumor sections include
mouse antibodies that recognize NeuN (MAB377; Chemi-
con International, Temecula, CA), the cyclin-dependent ki-
nase inhibitor, p27Kip1 (BD Transduction Laboratories, Lex-
ington, KY), and rabbit antibody against the proliferation
marker, Ki-67 (Vector Laboratories, Burlingame, CA). Rab-
bit polyclonal anti-Zic antibody was raised against a car-
boxy-terminal peptide (AVHHTAGHSALSSNFEWYV)
(Borghesani et al., 2002). Fluorescently labeled secondary
antibodies included Cy2-and Cy3-conjugates of goat-anti-
mouse IgG and goat-anti-rabbit IgG (Jackson Immuno-
Research Laboratories, West Grove, PA). Negative tissue
controls include adjacent and separate brain sections as well
as staining controls with only secondary antibodies.
For each genotype, Ptc/ and trkC/Ptc/, fro-
zen tissue sections from at least eight mice with tumors and
eight unaffected age-matched mice were analyzed sepa-
rately for phenotypic marker expression by using standard
immunocytochemical methods. Sections were rehydrated
and blocked with 4% normal goat serum (NGS; GibCo-
BRL, Grand Island, NY) and 0.1% NP-40 (Sigma) in PBS
for 60 min at 25°C. Normal mouse serum (NMS; 2%) was
included for use with monoclonal antibodies. For additional
permeabilization, sections were treated in 0.5% Triton-X
(Sigma) in PBS for 5–10 min at 25°C. For nuclear antigens
such as NeuN and Ki-67, antigen retrieval by microwaving
three times for 5 min in 0.01 M sodium citrate, pH 6.0,
improved sensitivity. Primary antibody incubations were
performed at the appropriate dilution in blocking buffer for
12–18 h at 4°C, followed by PBS washes and secondary
antibody incubations for 60 min at 25°C. Sections were
mounted after nuclear counterstaining with bisbenzimide
(Hoechst 33342, 10 M in PBS; Sigma) (Darzynkiewicz et
al., 1994) and examined with a Nikon E800 microscope.
Images were analyzed by using a SPOT RT color camera
and software (version 3.0, Diagnostic Instruments, Sterling
Heights, MI) and Metamorph software (v.4.6, Universal
Imaging, Downingtown, PA).
In situ hybridization and Northern blot analyses
Northern blot analysis of total cellular RNA using a
random oligonucleotide-primed (32P)-labeled trkC cDNA
probe prepared from a plasmid containing 513 bp of the
extracellular domain of human trkC cDNA (courtesy of
David Shelton, Genentech) was performed as previously
described (Kim et al., 1999). Target mRNA signals are
measured by using a PhosphorImager (Molecular Dynam-
ics, Sunnyvale, CA) and corrected for variations in sample
loading by comparison to internal 28S rRNA expression, as
previously described (Kim et al., 1999).
For in situ hybridization, digoxigenin-labeled antisense
and control sense riboprobes were prepared from linearized
plasmids encoding Ptc, cyclinD1, Nmyc, NeuroD1, and
Math1 (courtesy of Allen Bale, Yale University, New Ha-
ven, CT, and Qui Fu Ma, Dana-Farber Cancer Institute,
Boston, MA) (Kenney and Rowitch, 2000). Frozen tissue
sections were prepared from a minimum of five mice as
previously described (Zhao et al., 2002).
Proliferation analysis
To quantitate proliferation of murine medulloblastoma
cells and granule cell precursors by in vivo bromodeoxyuri-
dine (BrdU) incorporation, animals were injected intraperi-
toneally with BrdU in PBS (50 g per gm body weight;
Roche Molecular Biochemicals), as previously described
(Campana et al., 1988). After 60 min, mice were euthanized
and their tissues processed as described above. For immu-
nostaining of incorporated BrdU, frozen sections were per-
meabilized with 1% Triton-X in PBS at 25°C for 15 min,
treated with 0.1 M NaBH4, followed by denaturation in 2 N
hydrochloric acid (Fisher Scientific) for 45 min at 37°C, and
neutralization in two changes of 0.2 M sodium borate
(Sigma), then washed in PBS at 25°C. Primary incubation
with anti-BrdU monoclonal antibody (clone BMC9318 at 6
g/ml in 4% NGS/PBS; Roche Molecular Biochemicals)
for 60 min at 25°C was followed by washes and secondary
incubation with Cy2-or Cy3-conjugated secondary goat-
anti-mouse IgG antibodies (Jackson ImmunoResearch) for
30 min at 25°C. After nuclear counterstaining with bisben-
zimide (Hoechst 33342; 10 M in PBS), sections were
examined as above.
The proportion of BrdU-positive cells was determined by
counting BrdU-positive nuclei and total (bisbenzimide-
stained) nuclei in randomly selected high-power fields
(hpf). For each tumor specimen, 6–12 hpf were counted for
each of 6–12 sections by at least 2 blinded observers. For
normal granule cell analysis, representative cerebellar sec-
tions from midline rostral to caudal levels (e.g., lobules II,
VI, and IX) as well as lateral regions (lobule VI) from 8–12
mice were similarly processed and examined for each age
time point and genotype. Negative immunostaining controls
included BrdU-negative tumor sections and staining with
secondary antibody only. Positive controls included immu-
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nostaining with rabbit antibody against the Ki-67 prolifer-
ation marker as well as confirmatory staining of BrdU-
labeled neonatal mouse cerebellar sections containing
proliferating granule cell precursors.
Apoptosis analysis
Apoptotic cells were detected in frozen tissue sections by
terminal deoxynucleotide transferase-mediated dUTP nick
end-labeling (TUNEL) with digoxigenin-labeled nucleo-
tides using ApopTag Red reagents (Intergen, Purchase, NY)
including rhodamine (TRITC)-conjugated anti-digoxigenin
antibody, according to manufacturer’s instructions. The pro-
portion of TUNEL-positive cells was calculated by counting
TUNEL-positive nuclei divided by the number of total (bis-
benzimide-stained) nuclei in randomly selected high-pow-
ered fields. Since apoptotic nuclei were often fragmented,
foci of positive staining clustered less than 5 m apart were
counted as a single positive nucleus. Eight to twelve hpf
were counted for each of at least four sections from each of
six specimens by at least three blinded observers.
Results
The developmental effects of PTCH mutation have been
well described in humans with NBCCS (Gorlin, 1995). As
in NBCCS patients, mice with Ptc mutations can develop
spontaneous cerebellar tumors (Goodrich et al., 1997; Hahn
et al., 2000). Although homozygous null mutation of Ptc
(Ptc/) results in embryonic lethality, description of the
neurodevelopmental effects of Ptc heterozygosity on cere-
bellar development has been limited (Goodrich et al., 1997).
Heterozygous Ptc/ mice display markedly decreased
survival relative to their wt littermates primarily because of
cerebellar tumors that closely resemble human medulloblas-
tomas (P  0.0001, log-rank test). The Ptc/ mouse
tumors cause obvious symptoms of ataxia, dehydration, and
diminished activity that subsequently progress to death
within hours to days. Of Ptc/ mice observed between 5
and 54 weeks (wks) of age, approximately 9.8% developed
medulloblastomas (n 56) that presented with symptoms at
a median age of 26.9 wks. Since human medulloblastomas
may arise in the cerebellar granule cell lineage, we tested
whether Ptc mutation contributes to the initial stages of
tumorigenesis by globally deranging granule cell differen-
tiation and increasing the proliferation and/or decreasing the
apoptosis of granule cell precursors.
Only a subset of Ptc/ mouse granule cell precursors
display elevated proliferation
To address whether granule cell development proceeds
normally throughout the cerebellum in Ptc/ compared
with wt mice, we evaluated animals at postnatal day 4 (P4),
P8, P15, and 15 weeks of age. During the first postnatal
week, normal wt granule cell precursors undergo a burst of
proliferation causing marked expansion of the EGL. Direct
measurements of the proliferation by in vivo BrdU incor-
poration reveal 13.5  1.3% (mean  S.E.M.) of normal
granule cell precursors are in S-phase in the developing
EGL of P4 wt mouse pups (Fig. 1). Brisk proliferation
continues in P8 wt pups with 11.2  0.7% BrdU-positive
granule cell precursors, when the EGL achieves its maxi-
mum dimension of 8–12 cells thick. By the end of the
second postnatal week, the EGL shrinks to only 1–2 cells
thick with only 5.5  1.0% BrdU-positive nuclei in P15 wt
mice (Fig. 1). Thereafter, the EGL diminishes so that by
early adulthood (15 weeks of age) no BrdU uptake is de-
tectable in wt mice
Immunostaining for BrdU revealed similar overall label-
ing indices in the EGL of Ptc/ mice compared with their
wt littermates (Fig. 1). In Ptc/ mice, 15.2  1.0% and
10.1  0.6% of EGL granule cell precursors are BrdU-
positive at P4 and P8, respectively, like their wt littermates
(Figs. 1 and 2A). By P15, the shrinking EGL of Ptc/
mice contain 7.5  0.8% BrdU-positive granule cell pre-
cursors (Figs. 1 and 2B), and by 15 weeks, no appreciable
BrdU uptake is observed in the EGL. Similar trends in
immunostaining for the proliferation marker, Ki-67, were
also observed and correlate with BrdU incorporation data
(Fig. 2C and D) (Onda et al., 1996).
Although the overall proliferation rates of granule cell
precursors are similar to their wt littermates, Ptc/ mice
are susceptible to increased proliferation in a significant
subset of granule cell precursors. In 6 of 10 asymptomatic
P15 Ptc/ mice examined, we detected patches of intense
superficial cerebellar X-gal staining, as previously reported
(Goodrich et al., 1997). Microscopic examination reveal
that these X-gal-staining regions are thickened superficial
remnants of the EGL, typically measuring 10–20 cells thick
(Fig. 3A, C, and E) and significantly larger than adjacent
normal EGL regions (Fig. 3B and D). In 2 P15 Ptc/
animals, the hyperplastic EGL remnants formed overt nod-
Fig. 1. Increased in vivo BrdU-uptake by external granule cell layer (EGL)
rests/nodules and medulloblastomas (MB) from Ptc/ mice indicate
elevated proliferation compared with granule cell precursors from control
wild-type mice. Values expressed as mean of % BrdU positive nuclei in
EGL as determined by counting BrdU positive (by immunostaining) and
Hoechst 33342-stained cells in 6–12 high-powered fields of 6–12 cerebel-
lar sections from each of 8–12 mice. Error bars express standard error of
the mean (S.E.M.).
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ules (Fig. 3F–G) that morphologically resemble small tu-
mors, but otherwise share the characteristics of smaller EGL
rests (Fig. 3C and E). The cerebellar sites of these Ptc/
EGL rests and nodules varied widely from discrete patches
or regions within a single sulcus or at the tip of a single
folium to more diffuse involvement extending over multiple
folia, ranging from midline to lateral locations.
When analyzed for proliferation, these P15 Ptc/ EGL
Fig. 2. Expression of the cerebellar granule cell-specific transcription factor, Zic, and the neuronal nuclear protein, NeuN, peaks in postmitotic granule cells.
Double immunostaining in (A-B) with monoclonal -BrdU primary with Cy2-conjugated goat -mouse IgG secondary antibodies and primary rabbit
polyclonal -Zic with Cy3-conjugated goat -rabbit IgG secondary antibodies. (A) Zic expression increases in normal postmitotic premigratory granule cells.
Immunostaining of a normal P8 Ptc/ cerebellar section reveals BrdU uptake (Cy2; green), indicating proliferation of superficial granule cell precursors
in the EGL. Zic expression (Cy3; red) increases as granule cell precursors withdraw from the cell cycle in the inner EGL and migrate through the molecular
layer (ML) to the internal granule cell layer (IGL) (40). (B) Proliferation of granule cell precursors decreases as EGL shrinks after second postnatal week.
Immunostaining of a normal P15 Ptc/ cerebellar section shows decreased BrdU uptake (Cy2) in thinning EGL and continued Zic expression (Cy3) in
IGL (40). Double immunostaining in (C-D) with rabbit -Ki-67 and Cy3-conjugated goat -rabbit IgG antibodies with mouse -NeuN and Cy2-conjugated
goat -mouse IgG antibodies. (C) Normal P8 Ptc/ proliferating granule cell precursors do not express NeuN. Immunostaining of a normal P8 Ptc/
cerebellar section reveals Ki-67-positive (Cy3) proliferating superficial granule cell precursors in the EGL, in contrast to NeuN expression (Cy2) that is
limited to postmitotic granule cells of the deeper EGL and IGL (40 ). (D) Proliferation decreases as EGL shrinks after second postnatal week. Normal P15
Ptc/ cerebellar section shows decreased Ki-67 (Cy3) immunostaining in EGL remnant and continued NeuN (Cy2) immunostaining in IGL (40).
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Fig. 4. Neurodevelopmental gene expression pattern of Ptc/ mouse medulloblastomas is consistent with histogenesis in the granule cell lineage but
dysregulated relative to proliferation. In situ hybridization of Ptc/ mouse medulloblastomas with digoxigenin-conjugated antisense riboprobes reveal
diffuse expression of: (A) the cerebellar granule cell-specific bHLH transcription factor, Math1, normally limited to proliferating granule cell precursors
(20 ); (B) the neurogenic bHLH transcription factor, NeuroDl, at levels exceeding those in mature postmitotic granule cells of the IGL (20); (C) the
Shh-signaling target, cyclin D1, indicating ongoing proliferation of medulloblastoma cells (20 ); (D) the oncogene, Nmyc, that is overexpressed in human
desmoplastic medulloblastomas (20).
Fig. 3. EGL rests/nodules in Ptc/ cerebella display a pattern of marker expression and proliferation similar to normal granule cell precursors. Double
immunostaining in (A-B) with monoclonal -BrdU primary with Cy2-conjugated goat -mouse IgG secondary antibodies and primary rabbit polyclonal -Zic with
Cy3-conjugated goat -rabbit IgG secondary antibodies. (A) EGL rests from P15 Ptc/ contain granule cell precursors that are either BrdU-positive and
proliferating or Zic-positive and postmitotic. Double BrdU (Cy2) and Zic (Cy3) immunostaining reveals that proliferating cells are confined to the outer lamina of
the EGL, and that Zic expression increases in granule cell precursors as they withdraw from the cell cycle in the inner lamina of the EGL and in the IGL (40 ).
(B) Normal P15 Ptc/ EGL shows fewer proliferating BrdU-positive granule cell precursors in the superficial EGL and increased Zic expression in postmitotic
granule cells of the deeper EGL and mature granule cells of the IGL. Field shown adjacent to that in (A) shows decreased cell number in the normally thinner EGL
and mutually exclusive BrdU (Cy2) and Zic (Cy3) immunostaining (40). Double immunostaining in Panels C-D, and F with rabbit -Ki-67 and Cy3-conjugated
goat -rabbit IgG antibodies with mouse -NeuN and Cy2-conjugated goat -mouse IgG antibodies. (C) P15 Ptc/ EGL rests contain granule cell precursors that
express either the proliferation marker, Ki-67, or the postmitotic marker, NeuN. Double Ki-67 (Cy3) and NeuN (Cy2) immunostaining is parallel to BrdU uptake
and Zic (Cy3) immunostaining, respectively (shown above). Expression of the postmitotic neuronal marker, NeuN, is appropriately limited to nondividing granule
cells of deeper EGL and mature granule cells of the IGL (40). (D) Normal postmitotic P15 Ptc/ granule cell precursors and mature granule cells express NeuN.
Field shown adjacent to that in (C) shows decreased cell number in the normal thinner EGL and mutually exclusive pattern of Ki-67 (Cy3) and NeuN (Cy2)
immunostaining (20). (E) P15 Ptc/ EGL rests contain granule cell precursors that express either Ki-67 or p27Kip1. Double immunostaining for the
cyclin-dependent kinase inhibitor, p27Kip1 (with mouse -p27Kip1 and Cy2-conjugated goat -mouse IgG antibodies) and proliferation marker, Ki-67 (with rabbit
-Ki-67 and Cy3-conjugated goat -rabbit IgG antibodies), also shows mutually exclusive expression in the EGL and appropriate p27Kip1 expression in postmitotic
granule cells of deeper EGL and mature granule cells of IGL (40). Proliferating granule cell precursors in P15 Ptc/ EGL also form nodules that heterogeneously
express NeuN or p27Kip1. (F) Double NeuN (Cy2) and Ki-67 (Cy3) immunostaining of EGL nodule resembles pattern noted in EGL rests, shown in (C) (20). (G)
Double p27Kip1 (Cy2) and Ki-67 (Cy3) immunostaining of EGL nodule also reveals mutually exclusive expression pattern noted in EGL rests, shown in (E) (20).
In situ hybridizations of thickened P15 Ptc/ EGL rests with digoxigenin-conjugated antisense riboprobes reveal increased expression as indicated by dark
staining: (H) the Shh receptor, Ptc (20); (I) the cerebellar granule cells-specific bHLH transcription factor, Math1, (20 ); and (J) the oncogene, Nmyc (20)
expressed in proliferating granule cell precursors in the outer lamina of the EGL.
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rests/nodules display a higher percentage of BrdU-positive
nuclei (13.1 1.2%; P 0.004, ANOVA) (Figs. 1 and 3A)
compared with adjacent normal P15 Ptc/ EGL (7.5 
0.8%; Fig. 3B) or P15 wt EGL (5.5  1.0%). Immunostain-
ing for Ki-67 also labels EGL rests/nodules predominantly
in the outermost superficial regions (Fig. 3C and E) similar
to BrdU labeling and reminiscent of normal P4 to P8 EGL.
When analyzed separately, these Ptc/ EGL rests/nod-
ules display a clear growth advantage over neighboring
granule cell precursors and approximate the BrdU-incorpo-
ration rate of granule cell precursors in the P4 to P8 EGL
(Fig. 1). EGL rests/nodules present at earlier postnatal ages
are not readily distinguishable from normal neighboring
granule cell precursors, and are not numerous enough to
inflate the granule cell proliferation indices of Ptc/ mice
at P4 or P8 relative to their wt littermates
In addition to increased and protracted proliferation, the
focal accumulation of granule cell precursors in EGL rests/
nodules might involve decreased programmed cell death
(Krueger et al., 1995). However, our in situ TUNEL assays
of developing cerebellum do not reveal significant differ-
ences within the EGL of P4, P8, or P15 Ptc/ mice
compared with their wt littermates, indicating that the
Ptc/ EGL rests/nodules do not result from decreased
apoptosis of granule cell precursors (data not shown).
External granule cell layer rests/nodules express markers
of normal granule cell precursors
The EGL rests/nodules may arise in ptc/ mice be-
cause of disrupted cerebellar differentiation that results in
delayed proliferation arrest. The X-gal staining of P15
Ptc/ EGL rests/nodules reflects their expression of the
mutant lacZ-containing transgene, and parallels that of their
remaining intact Ptc allele (Fig. 3H) (Goodrich et al., 1997).
In addition to lacZ and Ptc, the EGL rests/nodules express
the oncogene, Nmyc, which is expressed by granule cell
precursors stimulated by Shh in vitro (Fig. 3J) (Kenney et
al., 2003; Zhao et al., 2002). The Ptc/ mouse EGL
rests/nodules also appropriately express transcription fac-
tors such as Math1 (Atoh-1), the mammalian atonal ho-
molog expressed by proliferating granule cell precursors in
the EGL and required for granule cell neurogenesis (Fig. 3I)
(Ben-Arie et al., 1997), and NeuroD (NeuroDI), the neuro-
genic basic helix–loop–helix (bHLH) transcription factor,
which becomes maximally expressed by postmitotic granule
cells during terminal differentiation.
The Ptc/ EGL rests/nodules also resemble normal
proliferating granule cell precursors in their minimal ex-
pression of mature granule cell markers. The dividing cells
in the EGL rests/nodules express the proliferation marker,
Ki-67, in addition to incorporating BrdU, but neither Ki-67
nor BrdU labeling overlaps with the expression of the post-
mitotic granule cell markers, NeuN or Zic, respectively
(Fig. 3A, C, and F). The Zic transcription factors are zinc-
finger-containing odd-paired homologs, including Zic
(Zic1), which is normally expressed at very low levels in
granule cell precursors of the superficial proliferative layer
of the EGL and achieves maximal expression in postmitotic
granule cells of the IGL (Figs. 2A, B, and 3B) (Aruga et al.,
1994). The EGL rests/nodules display lower levels of Zic
and only in those nonproliferating cells that do not incor-
porate BrdU (Fig. 3A). Like Zic, the neuron-specific nuclear
marker, NeuN, is also maximally expressed in mature post-
mitotic granule cells. NeuN upregulation normally coin-
cides with cell cycle withdrawal and/or terminal neuronal
differentiation (Mullen et al., 1992). In 15-day-old mouse
cerebellum, only rare cells in the normal EGL express NeuN
in contrast to mature postmitotic granule cells in the IGL
(Fig. 2D) (Sarnat et al., 1998). EGL rests/nodules express
NeuN only in Ki-67-negative or nonproliferating cells (Fig.
3C and F), comparable to mature IGL granule cells (Fig. 3C,
D, and F). Similarly, the cyclin-dependent kinase inhibitor,
p27Kip1, is upregulated in postmitotic granule cells and
found only in Ki-67-negative postmitotic cells in EGL rests/
nodules (Fig. 3E and G).
These data indicate that the granule cell precursors com-
prising the Ptc/ EGL rests/nodules observed in P15
Ptc/ mice appropriately express neuronal and immature
granule cell markers relative to their persistent proliferation
like those in normal P4 and P8 EGL, but fail to cease
dividing. This developmental defect represents an interme-
diate stage of tumorigenesis relative to the Ptc/ mouse
medulloblastoma phenotype.
Dysregulation of proliferation relative to granule cell
differentiation in murine medulloblastoma
In parallel analyses, murine medulloblastomas exhibit
evidence of aberrant differentiation compared with normal
granule cell precursors and Ptc/ EGL rests/nodules. The
Ptc/ mouse tumors appear similar to human medullo-
blastomas as densely cellular cerebellar mass lesions that
compress neighboring normal-appearing cerebellar tissue
without significant invasion across cortical layers. Murine
medulloblastomas heterogeneously display regions of nodu-
larity surrounded by thin acellular rims, areas of increased
vascularity, or smaller focal areas of hemorrhage or necro-
sis. Some murine tumors involve superficial regions corre-
sponding to EGL remnants, but are distinct from normal
granule cells in their microscopic appearance.
Immunostaining for in vivo BrdU incorporation by cer-
ebellar tumors in Ptc/ mice reveals 17.5  5.0% BrdU-
positive nuclei (mean S.E.M.; Fig. 1). These proliferation
data indicate a markedly elevated fraction of murine me-
dulloblastoma cells labeled in S-phase. Values for murine
tumors are higher than those obtained from normal granule
cell precursors in the developing EGL of P15 wt and
Ptc/ mouse pups.
Disruption of developmental programs in Ptc/mouse
medulloblastomas is apparent in their misexpression of neu-
rogenic transcription factors associated with postmitotic
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granule cell maturation. Like proliferating granule cell pre-
cursors and P15 Ptc/ EGL rests/nodules, murine medul-
loblastomas diffusely express Math1 RNA (Fig. 4A). How-
ever, the diffuse expression of NeuroD, NeuN, and Zic by
murine tumor cells contrasts with their ongoing growth. In
situ hybridizations reveal that NeuroD is expressed through-
out proliferating Ptc/ mouse tumors at levels exceeding
postmitotic differentiated granule cells in the IGL (Fig. 4B).
NeuN, a nuclear marker for normal postmitotic neurons, is
expressed by Ptc/ mouse medulloblastomas but not in
the same tumor cells that express the proliferation marker,
Ki-67 (Fig. 5A and C). Zic expression has been documented
in human medulloblastomas, and immunostaining reveals
elevated nuclear Zic expression throughout Ptc/ mouse
tumors at higher levels than even mature postmitotic gran-
ule cells (Fig. 5B) (Yokota et al., 1996). Zic is detected
predominantly in BrdU-negative cells, but double labeling
also reveals a Zic-positive subpopulation of proliferating
Fig. 5. Proliferating Ptc/ medulloblastomas inappropriately coexpress markers of proliferation and of postmitotic granule cells. (A) Double immuno-
staining for NeuN (with Cy2-conjugated secondary antibody) and Ki-67 (with Cy3-conjugated secondary antibody) shows heterogeneous NeuN expression
on a background of proliferating Ki-67-positive tumor nuclei (20). (B) Double immunostaining reveals diffuse BrdU uptake (with Cy2 conjugated
secondary antibody) and tumor expression of Zic (with Cy3-conjugated secondary antibody) (20). (C) Higher power view of section shown in (A) reveals
mutually exclusive expression of NeuN (Cy2) and Ki-67 (Cy3), indicating that NeuN is expressed in nonproliferating tumor cells (arrows indicate
NeuN/Cy2-positive nuclei; 60). (D) Higher power view of section shown in (B) reveals colabeling of BrdU and Zic, which is minimally expressed in normal
proliferating granule cell precursors [arrows indicate BrdU (Cy2) and Zic (Cy3) double-stained nuclei; 60].
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Fig. 6. Ptc/ mouse medulloblastomas resemble human medulloblastomas. (A) X-gal-staining of Ptc/ mouse medulloblastoma indicates upregulated
expression of lacZ- containing transgene that parallels expression of the intact Ptc allele (sagittal view). (B) Ptc/ mouse medulloblastoma reveal bands
of reticulin by histochemical staining (20). (C) Micrograph of hematoxylin-stained Ptch/ mouse medulloblastoma (20).
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tumors cells (Fig. 5D), indicating dysregulation of prolifer-
ation relative to Zic expression.
Murine medulloblastoma resemble desmoplastic human
medulloblastoma
Like human medulloblastomas, Ptc/ mouse tumor
cells are uniformly small with scant cytoplasm and high
nuclear:cytoplasmic ratios (Fig. 6C) (Goodrich et al., 1997).
Murine Ptc/ medulloblastomas are also similar to hu-
man tumors in their expression of homologous neuronal
markers and granule cell-specific transcription factors that
normally regulate granule cell precursor proliferation and
differentiation, which supports their origin in the granule
cell lineage: NeuroD, Math1, and Zic family members
(Aruga et al., 1994; Ben-Arie et al., 1997; Miyata et al.,
1999; Mullen et al., 1992; Rostomily et al., 1997). The in
situ hybridizations of Ptc/ mouse medulloblastomas re-
veal the upregulation of the Shh/Ptc-signaling targets, cy-
clinDI (Fig. 4C) and Nmyc, which are upregulated in Shh-
stimulated granule cell precursors and overexpressed in
human desmoplastic medulloblastoma (Fig. 4D) (Duman-
Scheel et al., 2002; Kenney and Rowitch, 2000; Kenney et
al., 2003; Pomeroy et al., 2002; Zhao et al., 2002).
The classic histologic subtype of human medulloblas-
toma appears densely cellular throughout, whereas acellular
reticulin-rich bands separating cellular nodules characterize
the desmoplastic variant. Although several investigators
have noted an association between desmoplastic histology
and Ptc mutation, the histologic appearance of Ptc/
mouse cerebellar tumors is not overtly desmoplastic (Dong
et al., 2000; Pietsch et al., 1997; Raffel et al., 1997). None-
theless, areas of decreased cellularity with tumor nodularity
are often observed in Ptc/ mouse medulloblastomas,
with surrounding acellular reticulin-containing bands, rem-
iniscent of desmoplastic human tumors (Fig. 6B). These
parallels support the molecular similarity of Ptc/ mouse
tumors in addition to their anatomic and histologic resem-
blance to human desmoplastic medulloblastomas.
Reducing trkC expression decreases apoptosis but not the
incidence of trkC/Ptc/ mouse medulloblastomas
One of the neuronal markers associated with the desmo-
plastic histologic subtype is TRKC, the transmembrane re-
ceptor for neurotrophin-3 (NT-3) that is increasingly ex-
pressed during normal granule cell maturation, as well as in
Ptc/ EGL rests/nodules and in primary human medul-
loblastomas (Pomeroy et al., 2002; Segal et al., 1992). In
order to test how misexpressed neurodevelopmental genes
modulate medulloblastoma growth, we examined tumors in
Ptc/ mice bearing additional mutation of trkC.
To generate Ptc/ mice with trkC mutation, we cross-
bred Ptc/ mice. Of the nine theoretically possible geno-
types of F1 offspring of trkC/  Ptc/ crosses, only
four genotypes were viable to reproductive age: wt, parental
Ptc/ and trkC/ strains, and double heterozygous
trkC/ Ptc/ mice. The absence of homozygous trkC
null (trkC/) offspring to survive to weaning, after the
previously reported survival limit of trkC/ pups, was not
surprising (Klein et al., 1994; Tessarollo et al., 1997). Dou-
ble heterozygous trkC/Ptc/ mice bred from Ptc/
and trkC/ parents show significantly diminished sur-
vival compared with wt littermates because of cerebellar
tumors (P  0.0001; log-rank test), like Ptc/ littermates
(P  0.91, log-rank test). Of double heterozygous trkC/
Ptc/ mice between the ages of 5 and 54 weeks, 13.4%
develop cerebellar tumors (n  11) like parental heterozy-
gous Ptc/ mice (9.8%; P  0.25; log-rank test), with a
similar median age of incidence at 30.6 weeks (P  0.73;
ANOVA) and mean of 27.0  14.1 wks (S.D.). These data
indicate that mutation of trkC does not alter the formation
and emergence of medulloblastoma on a Ptc/ back-
ground.
Medulloblastomas in trkC/Ptc/ mice are ana-
tomically and microscopically indistinguishable from
those in Ptc/ mice. Immunophenotypically, trkC/
Ptc/ mouse medulloblastomas are similar to
Ptc/ mouse tumors. Northern and in situ hybridiza-
tion analyses of cerebella and tumors from trkC/
Ptc/ mice reveal a similar pattern of granule cell
marker and neurodevelopmental gene expression (Table
1). In situ hybridizations reveal that trkC/Ptc/
mouse medulloblastomas express less trkC than Ptc/
mouse tumors (Fig. 7A and B) despite the variability
among different tumors. As in parental trkC/ mice,
Northern blot analysis of cerebellar RNA shows that
compound heterozygous trkC/Ptc/ mice express
less than two-thirds of the trkC levels found in wt or
Ptc/ littermates (data not shown).
Proliferation analysis of trkC/Ptc/ mouse medul-
loblastomas reveals similar in vivo BrdU incorporation in
19.6  5.4% of tumor cell nuclei, compared with Ptc/
mouse tumors (17.5  5%; P  0.63, ANOVA; Fig. 1).
However, examination of spontaneous apoptosis in murine
medulloblastomas in vivo reveals differences between
Ptc/ and trkC/Ptc/ tumor cells consistent with
the proapoptotic role of TrkC. When examined microscop-
ically for spontaneous apoptosis in randomly selected re-
gions, the trkC/Ptc/ mouse medulloblastomas dis-
played a lower proportion of TUNEL-positive nuclei, 4.8
0.6% (mean  S.E.M.) compared with 7.6  1.8% in
Ptc/ mouse tumors (Fig. 7C–E; P  0.015, ANOVA).
These differences indicate that diminished trkC expression
in murine medulloblastomas is associated with decreased
spontaneous apoptosis, analogous to low TRKC/NTRK3-
expressing human medulloblastomas (Kim et al., 1999; Se-
gal et al., 1994).
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Discussion
Persistent proliferation marks a subset of Ptc/
granule cell precursors
Because Ptc negatively regulates Shh signaling, investi-
gators have proposed that heterozygous Ptc mutation con-
tributes to medulloblastoma tumorigenesis by phenocopy-
ing the proliferative effects of Shh signaling (Wetmore et
al., 2000; Zurawel et al., 2000). Our results, however, indi-
cate that Ptc haploinsufficiency does not cause globally
increased proliferation of granule cell precursors during
early postnatal cerebellar development. Instead, we discov-
ered a subset of granule cell precursors that continue to
proliferate at rates comparable to normal development even
as proliferation effectively ceases for the remainder of the
EGL. Although Ptc haploinsufficiency could potentially de-
crease programmed cell death to promote the development
of these rests of persistently proliferating progenitors, we
found that early postnatal Ptc/ mice do not display
decreased granule cell apoptosis compared with their wt
littermates.
We calculated the proportion of cells in S-phase in each
high-powered microscopic field by dividing the number of
BrdU-positive nuclei by the total number of cells compris-
ing the entire thickness of the EGL. As a result, our counts
from the entire EGL indicate peak proliferation shortly after
birth and a steadily declining percentage of BrdU-positive
cells. This contrasts with previous reports of peak BrdU or
tritiated thymidine labeling at P8 that were based on counts
of cells only in the mitotically active outermost EGL sub-
lamina (Fujita et al., 1966). When similarly normalized, our
data agree closely with established figures and show dimin-
ishing proliferation during the second postnatal week as the
EGL markedly shrinks. We observed mitotically active
EGL rests and nodules in a majority of the asymptomatic
P15 Ptc/ mice examined. These abnormally proliferat-
ing granule cell precursors display a similar pattern of
marker expression as normal immature granule cell precur-
sors found in the EGL of P4 and P8 mice.
Expression of differentiation markers by Ptc/ murine
medulloblastoma supports histogenesis in the granule cell
lineage but it is dysregulated
In contrast to granule cell precursors in EGL rests/nod-
ules, murine medulloblastomas reveal dysregulated expres-
sion of neuronal markers and neurogenic transcription fac-
tors relative to normal granule cell proliferation and
differentiation. The proportion of Ptc/ mouse medullo-
blastoma cells that are actively proliferating as measured by
BrdU incorporation is comparable to figures reported for
primary human medulloblastoma (Gilbertson et al., 1997;
Hoshino et al., 1985; Ito et al., 1992; Murovic et al., 1986;
Onda et al., 1996; Yoshii et al., 1986). Their expression of
Ki-67 and cyclinD2 and the absence of p27Kip1 are consis-
tent with ongoing proliferation (Miyazawa et al., 2000;
Zhao et al., 2002). Our results show that murine medullo-
blastomas express not only high levels of MathI, cyclinD2,
and Ki-67 (normally restricted to proliferating granule cell
precursors), but they also express NeuN, NeuroD, and Zic at
levels normally associated with postmitotic and mature
granule cells. The aberrant expression of these mature gran-
ule cell markers in proliferating Ptc/ mouse medullo-
blastomas demonstrates that the tumor cells have taken
another step in the process of oncogenesis, clearly diverging
from the normal developmental pattern displayed by the
granule cell rests. Moreover, the expression of postmitotic
markers in proliferating cells is indicative of the emerging
pathological state as granule cell progenitors evolve into the
cells of a growing tumor.
Normal immature granule cells in the inner EGL with-
draw from the cell cycle and cease to express Math1 and
cyclinD2. Concurrently, the expression of trkC/Ntrk3, neu-
Table 1
Mouse medulloblastoma resemble human medulloblastoma and granule cell precursors
Marker Granule cell lineage Ptc/ mouse
medulloblastoma
trkC/Ptc/ mouse
medulloblastoma
Human
medulloblastomaEGL IGL
outer inner
Synaptophysin      /
NSE      
NeuroD1    / / 
NF-H (200 kDa)      
TrkC    /  /
GLI      variable
Math1      ND
NeuN      ND
Zic    / / 
BrdU uptake      
Ki-67      
Note. Bold entries indicate discordances between murine medulloblastomas and the granule cell lineage.
, Uniformly positive expression; , minimal to heterogeneous expression; , uniformly negative expression.
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Fig. 7. trkC/Ptc/ mouse medulloblastomas express less trkC and display less apoptosis compared with Ptc/ medulloblastomas. (A, D, and show
Ptc/ medulloblastomas, and B, E, and G show trkC/Ptc/ medulloblastomas.) trkC/Ptc/ mouse medulloblastomas express less trkC mRNA
compared with Ptc/ medulloblastomas. (A) In situ hybridization with digoxigenin-conjugated antisense riboprobe reveals diffuse expression of trkC in
a Ptc/ mouse medulloblastoma and adjacent normal cerebellum (20). (B) In situ hybridization with digoxigenin-conjugated antisense riboprobe reveals
diffusely decreased expression of trkC in a trkC/Ptc/ medulloblastoma (20). trkC mutation decreases apoptosis in trkC/Ptc/ medulloblas-
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rofilament (NF) subunits, p27Kip1, Nscl-1, NeuroD, and Zic
increases as postmitotic granule cells mature (Alder et al.,
1996; Katoh-Semba et al., 2000; Millen et al., 1995; Miyata
et al., 1999; Segal et al., 1992). NeuN is a nuclear protein
widely expressed in mature postmitotic neurons including
granule cells (Mullen et al., 1992). The heterogeneous ex-
pression of NeuN suggests that this subpopulation of NeuN-
positive medulloblastoma cells is not actively proliferating
as indicated by the lack of Ki-67 coexpression and that they
may instead represent asymmetric mitoses or differentiation
among tumor cells. In contrast, NeuroD is expressed in
every cell throughout murine medulloblastomas that con-
tinue to proliferate. Like NeuroD, Zic is found in primary
human and Ptc/ mouse medulloblastomas (Rostomily et
al., 1997; Yokota et al., 1996). Normally, Zic expression
increases dramatically in granule cells as they undergo pro-
liferation arrest and terminal differentiation (Aruga et al.,
1994). The overall pattern of marker expression in Ptc/
mouse medulloblastomas resembles but is distinct from the
persistently proliferating granule cell precursors found in
EGL rests/nodules.
Our results suggest that the Ptc/ EGL rests represent
granule cell precursors at an early stage of departure from
normal neurogenesis. A developmental defect occurring in
the setting of germline Ptc mutation arises only in a subset
of granule cell precursors of the EGL, rendering them sus-
ceptible to persistent proliferation. Although more than half
of P15 Ptc/ pups display EGL rests or nodules, only
10–15% of adult Ptc/ mice eventually develop medul-
loblastoma, indicating that the persistently proliferating
granule cell precursors are not committed to becoming
overtly malignant. Since most of these proliferating Ptc/
EGL rests do not progress to become medulloblastomas,
they instead represent an abnormally persistent pool of
vulnerable granule cell precursors capable of regression via
delayed differentiation or cell death. We hypothesize that
subsequent mutation(s) or other genetic dysregulation in
some of these susceptible precursors may confer a further
proliferative advantage, which in turn contributes to frank
tumor formation.
While our evidence indicates a multistep process in the
ontogeny of murine Ptc/ medulloblastomas, insights
about the molecular mechanisms that promote these steps
are just beginning to emerge. Wetmore et al. (2001) dem-
onstrated that TP53 mutation accelerates medulloblastoma
formation in a TP53/Ptc/ compound mutant mouse,
leading to complete penetrance of medulloblastoma forma-
tion. While loss of p53 function may directly promote de-
regulation of cell cycle control, it also is possible that p53
loss promotes the accumulation of other genetic mutations
that act in concert with Ptc haploinsufficiency to promote
the malignant phenotype. Since loss of Ptc heterozygosity
has not been found in murine Ptc/ medulloblastomas,
mutations of other genes may be the “second hit” that
promotes tumorigenesis.
Recent studies have also identified epigenetic mecha-
nisms that alter gene expression to promote tumorigenesis.
Igf2 is normally imprinted so that only the paternal allele is
expressed, and has emerged as a candidate gene for epige-
netic regulation in cancer (Reik et al., 2000). Hahn et al.,
(2000) found that Igf2 is required for Ptc/ mouse tu-
morigenesis since compound Ptc/Igf2/ mutant mice
fail to develop either medulloblastomas or rhabdomyosar-
comas. However, Hahn et al. did not find evidence for
epigenetic mechanisms, such as loss of imprinting or uni-
parental disomy, nor did they detect Igf2 amplification or
polyploidy in Ptc/Igf2/mouse rhabdomyosarcomas.
They did not report similar studies of Ptc/Igf2/
mouse medulloblastoma.
Genetic modifiers, often strain-dependent, are also influ-
ential in the phenotype of mutant mouse models of devel-
opment, and strain-specific effects were initially described
in the Ptc/ model (Goodrich et al., 1997; Hide et al.,
2002). Our experiments involved mutant mice with a mixed
background of C57B1/6 and 129Sv strains, and the overall
incidence and phenotype of tumors observed were in close
agreement with published results (Goodrich et al., 1997;
Wetmore et al., 2000).
To summarize, our results indicate that murine medullo-
blastoma tumorigenesis is a multi-stage process in Ptc/
mice. Our findings are consistent with general models of
carcinogenesis, in which transformed subclones emerge
from a susceptible population of cells through progressive
alterations in gene expression (Corcoran and Scott, 2001;
Hahn and Weinberg, 2002; Kinzler and Vogelstein, 1996;
Wu and Pandolfi, 2001). Further investigation will be
needed to determine whether these steps involve genetic or
epigenetic deregulation of gene expression.
Mouse medulloblastoma phenotype resembles human
medulloblastoma
The inappropriate coexpression of postmitotic granule
cell markers by dividing murine medulloblastomas indicates
disruption of the coordinated regulation of differentiation
with proliferation, and belies the simple model of arrested
development in a mitotically active granule cell precursor
that has been suggested for human medulloblastoma. Like
primary human medulloblastomas, Ptc/ mouse tumors
appear morphologically undifferentiated, but can also ex-
tomas compared with Ptc/ medulloblastomas. (C) Values expressed as mean of % TUNEL-positive nuclei determined from counting TUNEL/TRITC-
positive nuclei and Hoechst 33342-positive cells in 8–12 high-powered fields of at least 4 tumor sections from each of 6 mice. Error bars express S.E.M.
(D) TRITC-conjugated TUNEL assay of Ptc/ medulloblastoma (arrows indicate apoptotic nuclei, 40). (E) TRITC-conjugated TUNEL assays of
trkC/Ptc/ medulloblastoma (arrows indicate apoptotic nuclei, 40). (F) Hoechst 33342 nuclear counterstaining of same high-powered field as in (D)
(40). (G) Hoechst 33342 nuclear counterstaining of same field as in (E) (40).
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press markers of divergent phenotypes. Murine medullo-
blastomas also reveal regions of extracellular reticulin stain-
ing in patterns resembling the histologic hallmark of
desmoplastic medulloblastomas (McLendon et al., 1998;
Rorke, 1983).
Medulloblastomas in Ptc/ mice are representative of
the desmoplastic subset of human tumors, and provide an
experimental system for exploring issues of diagnostic and
therapeutic significance. We have reported the association
of clinical outcome with TRKC/NTRK3 expression (Segal et
al., 1994). The greater the level of TRKC/NTRK3, the better
the observed overall and progression-free survival. We also
previously reported that TRKC/NTRK3 expression in pri-
mary human medulloblastomas correlates with apoptosis in
situ, and that NT-3 activation of TrkC induces apoptosis of
tumor cells in vitro and in intracerebral xenografts in vivo
(Kim et al., 1999). Although studies of apoptosis in human
medulloblastoma have not revealed an association with
prognosis, the regulation of tumor growth by TrkC-medi-
ated apoptosis may underlie the prognostic value of TRKC/
NTRK3 expression or contribute to treatment-responsive-
ness. In order to demonstrate the role of TrKC-mediated
apoptosis, we generated tumor-forming double heterozy-
gous trkC/Ptc/ mice, by crossbreeding Ptc/ an-
imals with trkC/ heterozygous mice.
While the Ptc/ mouse medulloblastomas express
trkC at variable levels comparable to normal mouse brain,
the trkC/Ptc/ offspring resemble parental trkC/
mice and express decreased levels of trkC in their brains and
cerebellar tumors (Klein et al., 1994; Wetmore et al., 2000).
The trkC/Ptc/ mouse medulloblastomas are rela-
tively low trkC-expressing tumors, morphologically similar
to Ptc/ mouse tumors. The incidence and age distribu-
tion of trkC/Ptc/ medulloblastomas are also similar
to Ptc/ tumors, indicating that trkC mutation does not
alter early tumorigenesis. In addition to comparable prolif-
eration rates, trkC/Ptc/ mouse medulloblastomas
also express similar neuronal and granule cell markers.
However, decreasing trkC expression in trkC/
Ptc/ mouse medulloblastomas, relative to Ptc/
mouse tumors, diminishes their spontaneous apoptosis in
vivo analogous to low trkC-expressing human tumors. The
similarities in medulloblastoma incidence and phenotype
among trkC/Ptc/ and Ptc/ mice are consistent
with the limitation of medulloblastoma growth by TrkC-
mediated apoptosis after oncogenic events have transpired
rather than contributing to early tumorigenesis.
Our characterization of murine medulloblastoma pheno-
types reveals similarities to primary human medulloblas-
toma, supporting both their origin in and significant diver-
gence from the granule cell lineage. We demonstrate that
Ptc heterozygosity does not globally disrupt postnatal gran-
ule cell differentiation. Our findings instead support a model
for medulloblastoma tumorigenesis as a multistage process
beginning with Ptc mutation that predisposes a subset of
granule cell precursors to persistent proliferation, but not
decreased apoptosis, as seen in the EGL rests/nodules as an
intermediate stage of tumorigenesis. Subsequent transform-
ing events or mutations, may act as additional “second hits”
en route to medulloblastoma. The transformation from the
intermediate stage of a mitotically active but nonmalignant
granule cell rest to a frank medulloblastoma does not in-
volve TrkC-dependent apoptosis as shown by the similar
incidence rate and age distribution of medulloblastomas in
trkC/Ptc/ compound heterozygotes. Instead, the
medulloblastomas in trkC/Ptc/ mice display de-
creased tumor cell apoptosis further supporting the role of
TrkC signaling, once the tumor is already established, in
regulating later tumor growth. These results further clarify
the relationship between normal granule cell development
and medulloblastoma tumorigenesis, and establish the va-
lidity of the Ptc/ mouse as an experimental model sys-
tem for human medulloblastoma.
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